Press releases

Vectans Pharma / Press releases

Substipharm and Athena Pharmaceutiques Acquire Controlling Interest in Vectans Pharma to Drive Global Growth and Innovation

Read the press release
Press releases - 09/16/2025
zambon-02-2024

A common goal, to improve the lives of patients

Zambon and Vectans Pharma laboratories have entered into a partnership to ensure the marketing of Virpax®, Lauriad® Aciclovir 50mg, in France.

Read the press release
News / Press releases - 04/29/2024

Exclusive agreement with the Menarini group and Berlin Chemie for Sitavig®

Read the press release
Press releases - 03/07/2023

Exclusive agreement with Berlin Chemie for Sitavig® in Eastern Europe and the CIS region

Read the press release
Press releases - 09/20/2022

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Read the press release
Press releases - 08/26/2022

Nomination of François Boutignon as Chief Innovation and Technology Officer

Read the press release
Press releases - 03/24/2022

China approves commercialization for Oravig®

Read the press release
Press releases - 01/15/2021

Exclusive licensing agreement with m8 Pharmaceuticals

Read the press release
Press releases - 02/03/2020
230 Bureaux de la colline
92213 Saint-Cloud
France

contact@vectans.com

logo-footer-10

  FOLLOW US

Copyright © VECTANS PHARMA

Legal notices and privacy policy